Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|November 1, 1995
Disposition of maternal ketoconazole in breast milkM E Moretti, S Ito, G KorenCanadian Family Physician Medecin De Famille Canadien|May 9, 2001
Leflunomide: new antirheumatic drug. Effect on pregnancy outcomesE Kozer, M E Moretti, G KorenCanadian Family Physician Medecin De Famille Canadien|October 3, 2000
Which drugs are contraindicated during breastfeeding? Practice guidelinesM E Moretti, A Lee, S ItoJournal of Clinical Pharmacology|August 16, 2001
The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancyG Atanackovic, Y Navioz, M E Moretti, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|December 25, 2012
The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancyJ R Hutson, J N Matlow, M E Moretti, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|August 10, 2011
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockersA Walfisch, A Al-maawali, M E Moretti, et al.Reproductive Toxicology (Elmsford, N.Y.)|August 8, 2001
Fetal effects of cocaine: an updated meta-analysisA Addis, M E Moretti, F Ahmed Syed, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 1, 2014
The fetal safety of cetirizine: an observational cohort study and meta-analysisF Etwel, N Djokanovic, M E Moretti, et al.Lancet (London, England)|November 24, 1999
Reporting bias in retrospective ascertainment of drug-induced embryopathyB Bar-Oz, M E Moretti, G Mareels, et al.The Pharmacogenomics Journal|July 12, 2017
A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse eventsM E Moretti, D F Lato, H Berger, et al.Pageof 2